Danaher Current Debt increased by 46050.0% to $923.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 84.2%, from $501.00M to $923.00M. Over 5 years (FY 2020 to FY 2025), Current Debt shows a downward trend with a -28.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests higher near-term cash requirements, while a decrease may indicate successful refinancing or debt repayment.
This represents the portion of long-term debt obligations that are scheduled to mature and require repayment within the...
Peers in the life sciences sector typically manage this based on their overall capital structure and debt maturity profiles.
current_portion_long_term_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.00M | $7.00M | $8.00M | $10.00M | $10.00M | $705.00M | $591.00M | $1.57B | $1.59B | $2.55B | $1.70B | $1.75B | $701.00M | $1.20B | $505.00M | $501.00M | $502.00M | $23.00M | $2.00M | $923.00M |
| QoQ Change | — | -69.6% | +14.3% | +25.0% | +0.0% | >999% | -16.2% | +165.8% | +1.2% | +60.2% | -33.5% | +3.0% | -59.9% | +71.2% | -57.9% | -0.8% | +0.2% | -95.4% | -91.3% | >999% |
| YoY Change | — | — | — | — | -56.5% | >999% | >999% | >999% | >999% | +261.3% | +186.8% | +11.1% | -55.9% | -52.9% | -70.2% | -71.3% | -28.4% | -98.1% | -99.6% | +84.2% |